Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.2 USD | +0.19% | -0.55% | -9.87% |
05-09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.87% | 1.79B | |
+7.08% | 111B | |
+10.33% | 106B | |
-12.49% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.29% | 16.81B | |
+38.82% | 12.54B | |
-24.94% | 8.09B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx : Credit Suisse Adjusts Inhibrx' Price Target to $44 from$28, Keeps Outperform Rating